About the Authors
- Arto A. Palmu
-
* E-mail: arto.palmu@thl.fi
Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Tampere, Finland
- Hanna Rinta-Kokko
-
Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
- Hanna Nohynek
-
Affiliation Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland
- J. Pekka Nuorti
-
Affiliation Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland
- Terhi M. Kilpi
-
Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
- Jukka Jokinen
-
Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
Competing Interests
The authors are employees of the National Institute for Health and Welfare, which has received research funding from GlaxoSmithKline for a Nationwide effectiveness trial of the ten-valent pneumococcal conjugate vaccine. AAP, HRK, TMK, and JJ are coinvestigators in the trial. This does not alter our adherence to PLOS ONE policies on sharing data and materials as GlaxoSmithKline had no role in the current study. The funding received from GlaxoSmithKline was for another trial, not the current study.
Author Contributions
Conceptualization: AAP JJ. Data curation: AAP HR-K JJ. Formal analysis: HR-K JJ. Funding acquisition: TMK JJ. Investigation: AAP HR-K JJ. Methodology: AAP HR-K HN JPN TMK JJ. Project administration: JJ. Resources: TMK JJ. Supervision: TMK JJ. Validation: HR-K JJ. Visualization: AAP HR-K HN JPN TMK JJ. Writing – original draft: AAP. Writing – review & editing: AAP HR-K HN JPN TMK JJ.